This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES: Oligonucleotide & Peptide Therapeutics Content Hub
24/7 Access
Digital & In-Person
Menu

John Dodd, Ph.D.
Vice President, Preclinical Development at Palatin Technologies, Inc.
Speaker

Agenda Sessions

  • PL8177 OCD - Alignment of Receptor, Oral Formulation and Peptide for Maximal Therapeutic Ratio in IBD

    On Demand - Premium Only
    View Session

At this event

Prev
Next
Jesse Dong, PhD
Vice President, Peptide Chemistry
BioNTech

See John at TIDES: Oligonucleotide & Peptide Therapeutics Content Hub